Which peptides have the best evidence for your specific goal.
By Condition & Goal maps the questions people actually ask — which peptides have the best evidence for a torn tendon, for fat loss, for hair, for energy, for libido, for focus — to what the clinical record really supports. Each guide ranks the candidate peptides by evidence strength, not popularity, and is explicit about where the human data stops and the marketing begins.
Thymosin beta-4 (RGN-259) is the rare peptide with real, large human RCTs for the ocular surface — yet every pivotal Phase 3 missed its co-primary endpoint. A clinical-editorial ranking of what the dry-eye evidence actually supports in 2026.
A clinical, evidence-first look at the peptides pitched for lateral and medial epicondylitis — BPC-157 and TB-500/thymosin β-4 — and why both are graded C (preclinical only) for the elbow.
Skin, Hair & AestheticAn evidence-graded ranking of the topical matrikine and copper peptides marketed for collagen, elastin and firmness — GHK-Cu, Matrixyl, palmitoyl tripeptide-1 and Synthe'6 — separating small human RCTs from in-vitro mechanism and marketing.
Energy, Cognition & MoodA clinical, evidence-first look at the peptides marketed for ME/CFS — thymosin alpha-1, elamipretide (SS-31), MOTS-c and cerebrolysin. The honest headline: no peptide has a completed CFS efficacy trial.
Skin, Hair & AestheticAn evidence-graded ranking of the peptides marketed for cellulite — oral collagen peptides, GHK-Cu, AOD-9604 and HGH Fragment 176-191 — separating the one modest human signal from mechanism, marketing and WADA-banned research chemicals.
Energy, Cognition & MoodA clinical, evidence-graded look at the three peptides marketed for depression — Cerebrolysin, Selank and Semax — separating secondary-endpoint human data and preclinical antidepressant signals from marketing hype.
Injuries & OrthopedicsAn evidence-graded review of the peptides marketed for cartilage and meniscus repair. The honest 2026 verdict: no peptide has a placebo-controlled human trial showing cartilage regrowth or meniscus repair, and the only controlled human data belongs to pentosan polysulfate — which is not even a peptide.
Immune, Gut & LongevityA clinical, evidence-graded review of the five peptides marketed for cardiovascular and heart health — elamipretide, angiotensin-(1-7), thymosin β4, TB-500 and BPC-157 — separating real human trials from preclinical and marketing claims.
Injuries & OrthopedicsLL-37, GHK-Cu, thymosin β4/TB-500 and BPC-157 all have real wound-healing biology — but not a single controlled human burn trial. A clinical-editorial ranking of what the evidence actually supports in 2026.
Injuries & OrthopedicsA clinical, evidence-ranked look at the peptides marketed for back injury, spinal soft-tissue repair, and disc health — what the published data actually supports, and what is marketing.
Immune, Gut & LongevityAn evidence-first ranking of the peptides studied for autoimmune modulation — larazotide, thymosin alpha-1, ARA-290 and KPV — separating real human trials from preclinical promise, and flagging the bidirectional immune risk.
Injuries & OrthopedicsAn evidence-graded review of the peptides marketed for athletic recovery — BPC-157, ipamorelin, CJC-1295 and TB-500. The honest 2026 verdict: every one is Grade C or D for recovery as an outcome, none is FDA-approved, and all are WADA-banned at all times.
Energy, Cognition & MoodA clinical, evidence-graded look at the four peptides marketed for anxiety and stress — Selank, N-Acetyl Selank Amidate, Semax and DSIP — separating the single human anxiety trial from preclinical and marketing claims.
Immune, Gut & LongevityAn evidence-first ranking of the peptides most studied for aging and healthspan — elamipretide, GHK-Cu, thymalin, epitalon and MOTS-c — separating real human data from rodent and in-vitro hype.
Injuries & OrthopedicsAn evidence-graded review of the peptides marketed for ankle sprains, ATFL tears and Achilles injury. The honest 2026 verdict: no human RCT exists; the strongest case is preclinical (rat Achilles models), and PRP — not a peptide — has the better human ankle evidence.
Energy, Cognition & MoodA clinical-editorial breakdown of the peptides marketed for 'adrenal fatigue,' stress and burnout — starting from the fact that 'adrenal fatigue' is not a recognized diagnosis, then grading Selank, DSIP and thymosin alpha-1 honestly against human, animal and absent evidence.
Weight Loss & MetabolicBeyond Ozempic and Wegovy: a clinical-evidence ranking of the next-generation metabolic peptides — the dual and triple incretin agonists and amylin analogues — for weight loss in 2026.
Skin, Hair & AestheticAn evidence-graded ranking of the peptides studied for atrophic acne scarring — copper tripeptide, the TriHex matrikine blend, and Matrixyl — separating the small human adjunct data from in-vitro mechanism and marketing.
We rank by evidence strength, not by popularity or marketing. For each condition we look at the highest-quality human evidence available — randomized controlled trials first, then cohort and open-label studies — and grade each candidate A-D. A peptide with weak human data but strong rodent results is graded accordingly and ranked below better-evidenced options. Where no peptide has solid human evidence for a goal, we say so plainly rather than implying one works. Every ranking is informational, not a treatment recommendation.
No. These guides are educational and editorial. They explain what the evidence does and does not support for a given condition or goal, but they are not medical advice and they do not prescribe a protocol. Many peptides discussed are not FDA-approved and some are prohibited in sport. Any decision about your health should be made with a licensed clinician who knows your history, not from an article.
Popularity and evidence often diverge. Several heavily marketed peptides — including some best-sellers for injury recovery or fat loss — rest almost entirely on animal studies or anecdote, with no completed human trials. Our grading is conservative, so those compounds rank below peptides with genuine human data even when they are more famous. We always explain the gap between how a peptide is promoted and what has actually been proven in people.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.
